Novasep Further Strengthens Management Team
News May 06, 2015
Novasep has announced two new appointments to its executive committee (COMEX). Pierre-Louis Mikus joins as chief legal officer. Bertrand Waymel is promoted to group human resources director. Both appointees will be based at Novasep’s management center in Lyon Gerland, a vibrant biotech hub.
The executive appointments come at a time when Novasep is experiencing significant growth backed by solid financial prospects. The strong and positive dynamics of Novasep’s ‘Back to Basics’ program that has enabled it to acquire new projects is providing the opportunity to bring additional specialized skills and expertise on board.
“We are delighted to welcome Pierre-Louis and Bertrand to the COMEX team,” said Michel Spagnol, CEO of Novasep. “They will have key responsibilities at an exciting stage in Novasep’s development towards becoming a leading full service supplier to the life sciences. Their talent will contribute greatly to implementing our strategy and executing our excellence programs, further improving the quality of service we provide to our customers.”
Mr. Mikus has more than 10 years’ experience in the pharmaceutical industry, notably as vice president, legal, R&D and technical operations for the Ipsen Group. Prior to joining Novasep, he practiced law at the offices of HBC Avocats, advising companies in the life sciences sector.
Mr. Mikus will focus on improving and harmonizing internal legal processes and controls, managing corporate governance and advising on strategic business transactions. Mr. Mikus holds an LL.B degree in law from the University of Montreal and a master’s in management from ESCP Europe. He is also a member of the Quebec and Paris bars.
Since joining Novasep in 2012, Mr. Waymel has taken on increasing responsibilities within the company. He began as a human resources director for the Synthesis BU. Two years later he also took on the role of human resources manager for the corporate management team.
Among his objectives will be to make HR management a differentiator, enabling the further development and attraction of new talent. Mr. Waymel holds a master’s degree from INSEEC, with a specialization in human resources management.
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019